NIH-funded research NIH-funded research

Identifying biomarkers to predict outcomes from brain stimulation for epilepsy

Official title: Biomarkers to Predict Outcome from Responsive Brain Stimulation for Epilepsy

Funded at University of Pennsylvania · NIH-11092694 · Data updated 2026-11-12

This study is looking to find ways to predict how well people with hard-to-treat epilepsy will do with a special brain device called responsive neurostimulation, so they can get the best treatment possible.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2025
Award (this year)$1,105,222
NIH project number5R61NS125568-03
Project IDNIH-11092694 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with intractable epilepsy who are not suitable candidates for surgical intervention.

Less likely to help

Patients who have well-controlled seizures with medication or those who are not candidates for brain stimulation therapy may not benefit from this research.

What this research studies

This research aims to develop biomarkers that can predict how well patients with intractable epilepsy will respond to a brain stimulation device known as responsive neurostimulation (RNS). By analyzing clinical and electrophysiological data, the study will use machine learning techniques to create a predictive biomarker signature. This signature will help determine the most effective therapy for patients who have not responded to medication. The goal is to improve clinical decision-making and ensure that patients receive the most suitable treatment options.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients with epilepsy, potentially improving their quality of life.

How similar studies have gone: Other research has shown promise in using biomarkers for predicting treatment outcomes in epilepsy, but this specific approach using machine learning and federated data analysis is relatively novel.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Davis, Kathryn Adamiak — University of Pennsylvania
  • Study coordinator: Davis, Kathryn Adamiak

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.